Costco to Sell Ozempic and Wegovy for $499 a Month
The same price is already available on Novo Nordisk’s direct-to-consumer website, as well as at Walmart and CVS
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
41 percent of practices declined to schedule appointment for hypothetical patient weighing 465 lb; 52 percent lacked basic standards of care
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
Author says findings support previous clinical trial data showing efficacy of baricitinib in preserving beta cell function in T1D
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
ATG 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes
Recommendations Issued for Diagnosing, Managing Gastroparesis
12 conditional recommendations include one against two-hour gastric emptying testing and one in favor of four-hour testing
Diabetes Tied to Doubled Risk for Sepsis
Smoking, high blood sugar, and other chronic conditions heighten risk
FDA Grants Accelerated Approval for First Treatment for Barth Syndrome
Forzinity helps improve strength of muscle to straighten the leg and works by improving mitochondria structure and function
Clinical Practice Guidelines Issued for Diabetes Distress
Assessing diabetes distress should form a routine part of care, according to authors
Oral Orforglipron Yields Greater Weight Reductions Than Placebo
Significant mean change in body weight from baseline to week 72 seen with various dosages of orforglipron compared with placebo among adults with obesity
